m.Stock by Mirae AssetOpen Demat Account
m.Stock by Mirae Asset
Procter & Gamble Health Ltd logo

Procter & Gamble Health Ltd Share Price

Current price unavailable.
As on - | -
PharmaceuticalsSmall Cap

Volume Analysis

SPOT Pivot Levels

TypeClassicFibonacci
R1 5,152.075,129.82
R25,218.135,163.55
R35,294.975,218.13
PP5,075.23 5,075.23
S15,152.075,129.82
S24,932.334,986.92
S3 4,866.274,932.33

Ratios

ParticularsDec 2025Sep 2025Jun 2025Mar 2025Dec 2024
ROCE-65.17-61.4251.46
ROE-49.51-46.7838.75
EPS46.7453.3439.8736.8654.76

Peer Comparison

No data available
Scrip NamePriceDaily changeM CapPE Ratio1 Year Return

Corporate Action

April 6, 2026
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Procter & Gamble Health Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L99999MH1967PLC013726</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NIL</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: ZEAL RUPANI <br/> Designation: Company Secretary <br/> EmailId: SHAH.ZS@PG.COM</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: SHASHANK SROWTHY <br/> Designation: CFO Director <br/> EmailId: srowthy.sr@pg.com</div> </div> <div> <br/> Date: 06/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>

About Procter & Gamble Health Ltd

Equity img
Procter & Gamble Health Limited was erstwhile incorporated as E Merck (India) Limited in 1967. The Company's name was changed from E Merck (India) Limited to Merck Limited on March 27, 2002. Later, the name of the Company was changed to Procter & Gamble Health Limited on 6 May, 2019. The company was set up to take over the business of the Indian branch of Emeda Exports with all their assets and li...
ISIN :INE199A01012

Registered Office

Godrej One 8th Floor,Projshanagar Vikhroli (East)

Contact number

+ 91-22-62109000

Registrars

KFin Techologies Ltd
Karvy Selenium Tow-B 31&32 Financial Dist Nanakramguda Hyderabad-500032

Contact number

+ 91-40-67162222

Management

S Madhavan (Chairman)

Milind Thatte (Director)

Open IPO’s

View All

FAQs

The share price of Procter & Gamble Health Ltd on the BSE is - as on -